Fulcrum Therapeutics, Inc. (FULC) Financials

FULC Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 257.7 million 22.5 million
2023-09-30 278.9 million 23.4 million
2023-06-30 300.3 million 24.9 million
2023-03-31 321.1 million 24.9 million

FULC Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -23.2 million 3.4 million
2023-09-30 -23.0 million 3.7 million
2023-06-30 -21.0 million 3.4 million
2023-03-31 -24.3 million 4.3 million

FULC Net Income

No data available :(

FULC Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 236.2 million - 10.8 million
2023-09-30 257.1 million - 11.5 million
2023-06-30 278.2 million - 12.2 million
2023-03-31 297.8 million - 12.8 million

FULC Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 61.9 million
2023-09-30 61.8 million
2023-06-30 61.8 million
2023-03-31 59.7 million

FULC Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 77000 19.0 million 9.9 million 508000
2023-09-30 65000 18.2 million 10.0 million -
2023-06-30 195000 17.8 million 10.3 million -
2023-03-31 171000 16.7 million 11.5 million -

FULC Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 871000 508000
2023-09-30 759000 500000
2023-06-30 880000 600000
2023-03-31 295000 566000

FULC

Price: $7.51

52 week price:
2.25
13.70

Earnings Per Share: -1.59 USD

P/E Ratio: -4.91

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 493900

Market Capitalization: 527.7 million

Links: